↓ Skip to main content

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial

Overview of attention for article published in Journal of Clinical Oncology, November 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Citations

dimensions_citation
186 Dimensions

Readers on

mendeley
129 Mendeley
citeulike
1 CiteULike